Login / Signup

Prognostic markers of post-stroke depression (PROMoSD): study protocol of a prospective single-center observational study on raphe hypoechogenicity as a predictor of post-stroke depression.

Daniel RichterAndreas EbertLisa Mazul-WachQuirin RulandJeyanthan Charles-JamesRalf GoldGeorgios TsivgoulisGeorg JuckelChristos Krogias
Published in: Neurological research and practice (2022)
The results of PROMoSD will answer the question of whether screening of BRH after AIS improves the prediction of PSD occurrence. A positive result of this study could have direct consequences on psychiatric support after AIS by streamlining diagnostic and therapeutic algorithms. Trial registration ClinicalTrials.gov identifier no. NCT05580198.
Keyphrases
  • study protocol
  • depressive symptoms
  • randomized controlled trial
  • clinical trial
  • machine learning
  • sleep quality
  • risk assessment
  • mental health
  • deep learning
  • phase ii
  • physical activity
  • double blind